BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 8888221)

  • 1. Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging.
    Guthrie JA; Ward J; Robinson PJ
    Radiology; 1996 Nov; 201(2):347-51. PubMed ID: 8888221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging of cholangiocarcinoma.
    Manfredi R; Barbaro B; Masselli G; Vecchioli A; Marano P
    Semin Liver Dis; 2004 May; 24(2):155-64. PubMed ID: 15192788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
    Low RN; Sigeti JS
    AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
    Peterson MS; Baron RL; Murakami T
    Radiology; 1996 Nov; 201(2):337-45. PubMed ID: 8888220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation.
    Maetani Y; Itoh K; Watanabe C; Shibata T; Ametani F; Yamabe H; Konishi J
    AJR Am J Roentgenol; 2001 Jun; 176(6):1499-507. PubMed ID: 11373220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging of head and neck tumors: comparison of T1-weighted contrast-enhanced fat-suppressed images with conventional T2-weighted and fast spin-echo T2-weighted images.
    Ross MR; Schomer DF; Chappell P; Enzmann DR
    AJR Am J Roentgenol; 1994 Jul; 163(1):173-8. PubMed ID: 8010208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
    Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM
    AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma.
    Leyendecker JR; Gakhal M; Elsayes KM; McDermott R; Narra VR; Brown JJ
    J Comput Assist Tomogr; 2008; 32(2):178-84. PubMed ID: 18379298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double contrast MR imaging with iron colloid and Gd-DTPA in cholangiocellular carcinoma.
    Suto Y; Shimatani Y; Kato T; Kamba M; Ohuchi Y; Kodama F; Kato T; Ohta Y
    Acta Radiol; 1994 Nov; 35(6):632-3. PubMed ID: 7946691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal MR protocol for hepatic hemangiomas. Comparison of conventional spin-echo sequences with T2-weighted turbo spin-echo and serial gradient-echo (FLASH) sequences with gadolinium enhancement.
    Kim TK; Choi BI; Han JK; Jang HJ; Han MC
    Acta Radiol; 1997 Jul; 38(4 Pt 1):565-71. PubMed ID: 9240679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of malignant biliary obstruction: efficacy of fast multiplanar spoiled gradient-recalled MR imaging vs spin-echo MR imaging, CT, and cholangiography.
    Low RN; Sigeti JS; Francis IR; Weinman D; Bower B; Shimakawa A; Foo TK
    AJR Am J Roentgenol; 1994 Feb; 162(2):315-23. PubMed ID: 8310918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiocarcinoma: spectrum of appearances on MR images using current techniques.
    Worawattanakul S; Semelka RC; Noone TC; Calvo BF; Kelekis NL; Woosley JT
    Magn Reson Imaging; 1998 Nov; 16(9):993-1003. PubMed ID: 9839983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of pancreatic transplant dysfunction: value of gadopentetate dimeglumine-enhanced MR imaging.
    Fernandez MP; Bernardino ME; Neylan JF; Olson RA
    AJR Am J Roentgenol; 1991 Jun; 156(6):1171-6. PubMed ID: 2028861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging.
    Mahfouz AE; Hamm B; Taupitz M; Wolf KJ
    Radiology; 1993 Jan; 186(1):133-8. PubMed ID: 8416554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hilar cholangiocarcinoma: preoperative evaluation with a three dimensional volumetric interpolated breath-hold examination magnetic resonance imaging sequence.
    Yin LL; Song B; Xu J; Li YC
    Chin Med J (Engl); 2007 Apr; 120(8):636-42. PubMed ID: 17517176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous cell carcinoma of the oral cavity: MR findings and value of T1-versus T2-weighted fast spin-echo images.
    Yasumoto M; Shibuya H; Takeda M; Korenaga T
    AJR Am J Roentgenol; 1995 Apr; 164(4):981-7. PubMed ID: 7726062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning.
    Masselli G; Gualdi G
    Abdom Imaging; 2008; 33(4):444-51. PubMed ID: 17638040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns.
    Strouse PJ; Prince MR; Chenevert TL
    Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T.
    Whitney WS; Herfkens RJ; Jeffrey RB; McDonnell CH; Li KC; Van Dalsem WJ; Low RN; Francis IR; Dabatin JF; Glazer GM
    Radiology; 1993 Dec; 189(3):863-70. PubMed ID: 8234717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.